← Leaderboards
Ronald Lindsay
Zebra Biologics, Inc.
$77,177
Attributed
$308,708
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$308,708 · 1
By mechanism
R41$308,708 · 1
Top collaborators
- Alexander I. Agoulnik1 shared
- Irina Agoulnik1 shared
- Peter S Distefano1 shared
Most similar at Zebra Biologics, Inc.
Same institution · by research overlap
- Peter S Distefano$334,595
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAmino AcidsAnimal ModelAnimalsAntibodiesAntibody EngineeringAntifibrotic TreatmentAnti-Inflammatory AgentsApplications GrantsBaseBiologicalBirthBloodBoneBzlf1 GeneCarbon TetrachlorideCardiovascular DiseasesCardiovascular SystemCellular AssayCentrilobular Hepatic NecrosisCholineChronicCirrhosisAcute